The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells
Open accessAbstract
Most antibiotics with bactericidal activity require that the bacteria be actively dividing to produce rapid killing. However, in many infections, such as endocarditis, prosthetic joint infections, and infected embedded catheters, the bacteria divide slowly or not at all. Daptomycin is a lipopeptide antibiotic with a distinct mechanism of action that targets the cytoplasmic membrane of gram-positive organisms, including Staphylococcus aureus . Daptomycin is rapidly bactericidal against exponentially growing bacteria (a 3-log reduction in 60 min). The objectives of this study were to determine if daptomycin is bactericidal against nondividing S. aureus and to quantify the extent of the bactericidal activity. In high-inoculum methicillin-sensitive S. aureus cultures in stationary phase (10 10 CFU/ml), daptomycin displayed concentration-dependent bactericidal activity, requiring 32 μg/ml to achieve a 3-log reduction. In a study comparing several antibiotics at 100 μg/ml, daptomycin demonstrated faster bactericidal activity than nafcillin, ciprofloxacin, gentamicin, and vancomycin. In experiments where bacterial cell growth was halted by the metabolic inhibitor carbonyl cyanide m -chlorophenylhydrazone or erythromycin, daptomycin (10 μg/ml) achieved the bactericidal end point (a 3-log reduction) within 2 h. In contrast, ciprofloxacin (10 μg/ml) did not produce bactericidal activity. Daptomycin (2 μg/ml) remained bactericidal against cold-arrested S. aureus , which was protected from the actions of ciprofloxacin and nafcillin. The data presented here suggest that, in contrast to that of other classes of antibiotics, the bactericidal activity of daptomycin does not require cell division or active metabolism, most likely as a consequence of its direct action on the bacterial membrane.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Mechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
THE STATIONARY PHASE OF THE BACTERIAL LIFE CYCLE
Kolter, R., Siegele, D. A., & Tormo, A. (1993) · Annual Review of Microbiology · doi:10.1146/annurev.mi.47.100193.004231 · Cited by 820
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Self-citationStraus, S. K., & Hancock, R. E. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.009 · Cited by 446
Anderl, J. N., Zahller, J., Roe, F., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1251-1256.2003 · Cited by 355
Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin
Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297
LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4665-4672.2004 · Cited by 284
Bryan, L. E., & Kwan, S. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.6.835 · Cited by 249
Fux, C. A., Wilson, S., & Stoodley, P. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4486-4491.2004 · Cited by 240
Daptomycin disrupts membrane potential in growing Staphylococcus aureus
Alborn, W. E., Allen, N. E., & Preston, D. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2282 · Cited by 213
Somerville, G. A., Chaussee, M. S., Morgan, C. I., Fitzgerald, J. R., Dorward, D. W., Reitzer, L. J., & Musser, J. M. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6373-6382.2002 · Cited by 196
Canepari, P., Boaretti, M., Lleò, M. M., & Satta, G. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1220 · Cited by 166
Barry, A. L., FUCHS, P. C., & Brown, S. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1919-1922.2001 · Cited by 158
Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032
Allen, N. E., Hobbs, J. N., & Alborn, W. E. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1093 · Cited by 151
Differential Antibiotic Susceptibilities of Starved Mycobacterium tuberculosis Isolates
Xie, Z., Siddiqi, N., & Rubin, E. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4778-4780.2005 · Cited by 136
Lamp, K. C., Rybak, M. J., Bailey, E. M., & Kaatz, G. W. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2709 · Cited by 131
Lakey, J. H., & Ptak, M. (1988) · Biochemistry · doi:10.1021/bi00413a009 · Cited by 130
Chatterjee, I., Becker, P., Grundmeier, M., Bischoff, M., Somerville, G. A., Peters, G., Sinha, B. N. M., Harraghy, N., Proctor, R. A., & Herrmann, M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.13.4488-4496.2005 · Cited by 116
Laganas, V. A., Alder, J. D., & Silverman, J. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2682-2684.2003 · Cited by 87
Self-citationHerbert, D., Paramasivan, C. N., Venkatesan, P., Kubendiran, G., Prabhakar, R., & Mitchison, D. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2296 · Cited by 86
Wise, R. A. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.4.563 · Cited by 71
Labthavikul, P., Petersen, P. J., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3967-3969.2003 · Cited by 55
Lakey, J. H., & LEA, E. J. A. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90217-8 · Cited by 34
Cited by
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Ramalingam, B., Parandhaman, T., & Das, S. K. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00161 · Cited by 520
Applying insights from biofilm biology to drug development — can a new approach be developed?
Bjarnsholt, T., Ciofu, O., Molin, S., Givskov, M., & Høiby, N. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4000 · Cited by 516
Metadata
- Authors
- Mascio, C. T. M., Alder, J. D., & Silverman, J. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-12
- Volume
- 51
- Issue
- 12
- Pages
- 4255-4260
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2157265409
- Cited by
- 276
- References
- 26
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.